Found: 6
Select item for more details and to access through your institution.
First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti–IL-20 Monoclonal Antibody in Patients with Psoriasis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0134703
- By:
- Publication type:
- Article
A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 6, p. 1438, doi. 10.1002/art.39083
- By:
- Publication type:
- Article
Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injection.
- Published in:
- Reproductive Biology & Endocrinology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12958-022-01016-y
- By:
- Publication type:
- Article
OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2011, v. 26, n. 12, p. 4095, doi. 10.1093/ndt/gfr363
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of the Anti-Interleukin-20 Monoclonal Antibody NNC0109-0012 in Healthy Volunteers and Patients with Psoriasis or Rheumatoid Arthritis.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 3, p. 228, doi. 10.1007/s12325-015-0191-7
- By:
- Publication type:
- Article